Get started
Work

Abstract P5-17-12: First-in-human expansion study of oral PMD-026 in metastatic triple negative breast cancer patients

Year: 2022
Type: conference-abstract
DOI: 10.1158/1538-7445.sabcs21-p5-17-12
Authors: Muralidhar Beeram, Judy S. Wang, Lida A. Mina, Pavani Chalasani, Rebecca A. Shatsky, Robert Wesolowski, Sara A. Hurvitz, Meghna S. Trivedi, Hyo S. Han, Amita Patnaik, My-my Huynh, Aarthi Jayanthan, Mary Rose Pambid, Lambert Yue, Gerrit Los, Sandra E. Dunn, Andrew Dorr
Institutions: South Texas Accelerated Research Therapeutics, Johns Hopkins University, Johns Hopkins Medicine, University of Arizona Cancer Center, UC San Diego Health System, University of California San Diego, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Columbia University Irving Medical Center, Moffitt Cancer Center
Language: English
Subfield: Cancer Research
Open Access status: closed
OpenAlex ID: W4221133475
Cites:
Cited by:
Related to: 10